The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells

International Immunopharmacology

Volumn 7, Issue 13, 2007, Pages 1813-1818

  Shin, Seung Heon ^a   Ye, Mi Kyung ^a   Kim, Hae Sic ^b   Kang, Hyung Suk ^b  

^a Catholic University of Daegu   (South Korea)

^b Cluster Instruments Corporation   (South Korea)

Author keywords

Activation; Cytokine; Nano silver; Peripheral blood mononuclear cell; Proliferation

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 5; MEDISIL; NANOPARTICLE; NANOSILVER; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTI-INFLAMMATORY AGENTS; CELL PROLIFERATION; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERFERON TYPE II; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; NANOPARTICLES; SILVER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35748933519     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.08.025     Document Type: Article

References (14)

1. 3 has a direct effect on naïve CD4+ T cells to enhance the development of Th2 cells. J Immunol 167 (2001) 4974-4980
2. McHugh S.M., Rifkin I.R., Deighton J., Wilson A.B., Lachmann P.J., Lockwood C.M., et al. The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 99 (1995) 160-167
3. Aiken J.D., and Finke R.G. A review of modern transition-metal nanoclusters: their synthesis, characterization, and applications in catalysis. J Mol Catal A Chem 145 (1999) 1-44
4. Slawson R.M., Lee H., and Trevors J.T. Bacterial interactions with silver. Biometals 3 (1990) 151-154
5. Bach A., Eberhardt H., Frick A., Schmidt H., Bottiger B.W., and Martin E. Efficiency of silver-coating central venous catheters in reducing bacterial colonization. Crit Care Med 207 (1999) 491-496
6. Samuel U., and Guggenbichler J.P. Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int J Antimicrob Agents 23S1 (2004) S75-S78
7. Darouiche R.O. Anti-infective efficacy of silver-coated medical prostheses. Clin Infect Dis 29 (1999) 1371-1377
8. Chambers C.W., Proctor C.M., and Kabler P.W. Bactericidal effect of low concentration of silver. JA Water Works Assoc 54 (1962) 208-214
9. Thurman R.B., and Gerba C.H.P. The molecular mechanisms of copper and silver ion disinfection of bacteria and virus. Crit Rev Environ Control 18 (1989) 295-315
10. Greil J., Spies T., Boswald M., Bechert T., Lugauer S., Regenfus A., et al. Analysis of the acute toxicity of the Erlanger silver catheter. Infection 27 (1999) 38-42
11. Lee K.J., Lee Y.I., Shim I.K., Joung J., and Oh Y.S. Direct synthesis and bonding origins of monolayer-protected silver nanocrystals from silver nitrate through in situ ligand exchange. J Colloids Interface Sci 304 (2006) 92-97
12. Rowland T.L., McHugh S.M., Deighton J., Dearman R.J., Ewan P.W., and Kimber I. Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells. Immunopharmacology 40 (1998) 11-20
13. Mosmann T.R., and Coffman R.L. Th1 and Th2 cells: Different patterns of lymphokine secretion leads to different functional properties. Annu Rev Immunol 7 (1989) 145-173
14. Del Prete G.F., De Carli M., Almerigogna F., Giudizi M.G., Biagiotti R., and Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150 (1993) 353-360